Neurorestorative treatment of stroke: Cell and pharmacological approaches
Open Access
- 1 October 2006
- journal article
- review article
- Published by Springer Nature in NeuroRX
- Vol. 3 (4) , 466-473
- https://doi.org/10.1016/j.nurx.2006.07.007
Abstract
There is a compelling need to develop cell and pharmacological therapeutic approaches to be administered beyond the hyperacute phase of stroke. These therapies capitalize on the capacity of the brain...Keywords
This publication has 121 references indexed in Scilit:
- Vascular endothelial growth factor mediates atorvastatin-induced mammalian achaete-scute homologue-1 gene expression and neuronal differentiation after stroke in retired breeder ratsNeuroscience, 2006
- N-cadherin mediates nitric oxide-induced neurogenesis in young and retired breeder neurospheresNeuroscience, 2006
- Nitric oxide regulates Angiopoietin1/Tie2 expression after strokeNeuroscience Letters, 2006
- Chronic treatment of DA-8159, a new phosphodiesterase type V inhibitor, attenuates endothelial dysfunction in stroke-prone spontaneously hypertensive ratLife Sciences, 2006
- Biphasic effects of exogenous VEGF on VEGF expression of adult neural progenitorsNeuroscience Letters, 2006
- Adrenomedullin Enhances Therapeutic Potency of Mesenchymal Stem Cells After Experimental Stroke in RatsStroke, 2005
- A novel endogenous erythropoietin mediated pathway prevents axonal degenerationAnnals of Neurology, 2004
- The role of erythropoietin in regulating angiogenesisDevelopmental Biology, 2004
- A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemiaTransfusion and Apheresis Science, 2004
- Role of angiogenesis in patients with cerebral ischemic stroke.Stroke, 1994